XML 51 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Operating Activities    
Net Income $ 265,136 $ 950,427
Bad debt expenses 14,842 39,332
Depreciation expense 103,043 34,158
Amortization expense 10,859 10,531
Stock based compensation 36,251 46,538
Loss on disposal of fixed assets 5,450 28,571
Changes in operating assets and liabilities:    
(Increase)/Decrease in commission receivable 130,560 (151,415)
(Increase)/Decrease in enrolment fee receivable 2,470 (1,580)
(Increase)/Decrease in deposit and prepayment 70,142 (50,322)
(Increase)/Decrease in fiduciary asset (208,736) (1,098,078)
(Increase)/Decrease in other receivable 15,655 (29,991)
Increase/(Decrease) in accounts payable 261,822 375,709
Increase/(Decrease) in claims payable 17,929 16,868
Increase/(Decrease) in other payable (520,143) (53,141)
Increase/(Decrease) in accrued expenses (41,142) (98,661)
Increase/(Decrease) in deferred revenue 7,000 7,000
Increase/(Decrease) in income tax payable / receivable 77,643 202,570
Net cash provided by operating activities 248,781 228,516
Investing Activities    
Cash paid for purchase of fixed assets (139,874) (22,275)
Net cash used in investing activities (139,874) (22,275)
Financing Activities    
Dividend paid to non-controlling shareholders (125,640) (128,718)
Borrowings on related party debt 9,858 69,947
Principal payments on related party debt (49,602) (62,782)
Net cash (used) in financing activities (165,384) (121,553)
Net (decrease) / increase in cash and cash equivalent (56,477) 84,688
Effect of exchange rate changes on cash and cash equivalent 3,437 13,327
Initial cash and cash equivalent 8,203,957 8,051,872
Final cash and cash equivalent 8,150,917 8,149,887
Supplemental Disclosures of Cash Flow Information:    
Cash paid / (receive) during year for interest 0 810
Cash paid / (receive) during year for income taxes (3,174) 0
Non-Cash Transactions    
Dividend received 8,026 6,692
Purchase price allocation adjustment 0 40,729
Change in fair value for Available-for-sales securities $ 42,770 $ 11,629